GlassScriptPhysician profile
Sajal C Dutta
NPI 1528055548
$9,823.82
in general payments reported to CMS, 2019-2025
38 companies · $541 in 2025
The $541 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,433 · 2020: $606 · 2021: $88.55 · 2022: $415 · 2023: $2,024 · 2024: $2,717 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578 · Travel and Lodging: $2,568 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,577.91 |
| Travel and Lodging | $2,568.40 |
| Education | $135.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,236.71 | 2019-2020 | |
| Boston Scientific Corporation | $1,767.93 | 2019-2024 | Lumenis Pulse 120h, Rezum Generator, Moses 550 Dfl |
| Teleflex LLC | $1,513.36 | 2021-2024 | Urolift |
| Coloplast Corp | $1,132.94 | 2019-2022 | |
| Abbvie INC. | $370.69 | 2019-2024 | Botox |
| Pfizer INC. | $364.38 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.04 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $318.93 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $238.74 | 2019-2023 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $183.94 | 2023-2024 | Gemtesa, Orgovyx |
| Abbott Laboratories | $139.68 | 2024 | Amplatzer |
| Northgate Technologies, INC. | $92.00 | 2022 | |
| Tolmar, INC. | $83.20 | 2023-2024 | |
| Accord Healthcare, INC. | $80.32 | 2024-2025 | |
| Ethicon US, LLC | $79.69 | 2024-2025 | Echelon; Endopath, Echelon Flex |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajal Dutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.